Nanotechnology-based strategies in parasitic disease management: from prevention to diagnosis and treatment

R Tiwari, RP Gupta, VK Singh, A Kumar, Rajneesh… - ACS …, 2023 - ACS Publications
Parasitic infections are a major global health issue causing significant mortality and
morbidity. Despite substantial advances in the diagnostics and treatment of these diseases …

[HTML][HTML] Cyclodextrin Complexes for the Treatment of Chagas Disease: A Literature Review

F Taio, A Converti, ÁAN Lima - International Journal of Molecular …, 2024 - mdpi.com
Cyclodextrins are ring-shaped sugars used as additives in medications to improve solubility,
stability, and sensory characteristics. Despite being widespread, Chagas disease is …

New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease

SMF Murta, PA Lemos Santana… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Benznidazole, the drug of choice for treating Chagas Disease (CD), has
significant limitations, such as poor cure efficacy, mainly in the chronic phase of CD …

[HTML][HTML] Nanomedicines against Chagas disease: a critical review

MJ Morilla, K Ghosal… - Beilstein Journal of …, 2024 - beilstein-journals.org
Chagas disease (CD) is the most important endemic parasitosis in South America and
represents a great socioeconomic burden for the chronically ill and their families. The only …

Red sacaca essential oil-loaded nanostructured lipid carriers optimized by factorial design: cytotoxicity and cellular reactive oxygen species levels

SSD Chura, KAS Memória, AT Lopes… - Frontiers in …, 2023 - frontiersin.org
Amazonian flora includes several species with the potential to develop pharmaceutical and
biotechnological products. The essential oils from Amazonian species possess some …

[PDF][PDF] When nanomedicines meet tropical diseases

K Van Bocxlaer, G Muraca, ME Ruiz, RC Gambaro… - beilstein-journals.org
Chagas disease is a neglected endemic disease prevalent in Latin American countries,
affecting around 8 million people. The firstline treatment, benznidazole (BNZ), is effective in …